achieved sales totaling 27 billion dinars during the year.

The Ministry quoted a statement reported for "Shafaq News", that “ Director General of the company , Falah Hassan Saleh as saying that the value of sales declined during the fourth quarter of 2014 to nearly 6 billion dinars because of the security conditions of the country, indicating that the impact on the marketing sales movement If the company compared it to the same period of 2013, which was estimated at more than 8.5 billion Iraqi dinars.

He announced the presence of large amounts of production ready for marketing required by medical stores, adding that the security situation has prevented their access to marketing outlets.

He said that the company is ready to equip all government and private sectors in various types of produced medicine as well as the willingness to introduce new products for the treatment of various diseases and competitive prices consistent with the level of per capita income of the Iraqi part of its production for 2015.

Falah said the company continues to keep pace with the development in the global pharmaceutical industry and maintain the reputation of its products characterized by precision and quality through the development and change the shapes of some pharmaceutical preparations and the method of packaging using the latest equipment.